FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/03/2022
Voltar para busca
Dado oficial do USPTO
LAMPLEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
26/03/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 35
Data de depósito
20/07/2020
Data de registro
14/09/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/09/2021
Última transação
14/09/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
KR
Examinador
KON, ELISSA
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CellSafe
Representantes
Dennis S. Prahl, Esq. Ladas & Parry LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic agents for pharmaceutical use; chemical preparations for use in DNA for medical purposes; biological reagents for medical purposes; reagents for use in medical genetic testing; medical diagnostic test strips for blood analysisurine analysis; diagnostic test reagents for medical purposes for testing body fluids for microorganisms; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical purposes; diagnostic reagents for medical purposes; clinical medical diagnostic reagents; reagents for medical use; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; drugs for medical purposes for treating infectious and metabolic diseases
Classe 10
Medical diagnostic apparatus and instruments for monitoring infectious and metabolic diseases; diagnostic apparatus for medical purposesmolecular diagnostic apparatus; in vitro diagnostic devices for medical purposes for monitoring infections; medical instruments for infectious disease testing; medical diagnostic apparatus for testing for bacteria and virus; miniaturized medical sensors for use in gene analysis and diagnosis; medical apparatus and instruments other than for dental purposes for monitoring infectious and metabolic diseases; apparatus for carrying-out diagnostic tests for medical purposes for testing DNA and RNA samples; medical apparatus and instruments in the fields of clinical diagnosisfor diagnostic uses for infectious and metabolic diseases; diagnostic apparatus and instruments for medical purposes for diagnostic uses for infectious and metabolic diseases; medical instruments to measure blood pressurecardiac output and other physiological and cardiovascular parameters; medical apparatuspolymerase chain reaction equipment; fluid injectors for medical purposes; syringes for injection of medical substances
Classe 35
promoting the goods and services of others by means of operating an on-line comprehensive shopping mall with links to the retail web sites of others; business intermediary services relating to matching of potential private investors with entrepreneurs in the field of mail order by telecommunications who need funding; wholesale store services featuring medical diagnostic test strips; retail store services featuring medical diagnostic test strips; wholesale store services featuring diagnostic test reagents for medical purposes; retail store services featuring diagnostic test reagents for medical purposes; wholesale store services featuring clinical diagnostic reagents; retail store services featuring clinical diagnostic reagents; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring medical diagnostic apparatus and instruments; retail store services featuring medical diagnostic apparatus and instruments; wholesale store services featuring bacteria and virus testing apparatus; retail store services featuring bacteria and virus testing apparatus; wholesale store services featuring medical apparatus and instruments other than for dental purposes; retail store services featuring medical apparatus and instruments other than for dental purposes; wholesale store services featuring syringes for injection of medical substances; retail store services featuring syringes for injection of medical substances; wholesale store services featuring apparatus for medical purposes; retail store services featuring apparatus for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/03/2022
FIMP
FINAL DISPOSITION PROCESSED
03/03/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/12/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
14/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/06/2021
PUBO
PUBLISHED FOR OPPOSITION
29/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
26/05/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/05/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
26/05/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/05/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
26/05/2021
PBER
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
20/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/05/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/05/2021
ATRV
ATTORNEY REVIEW COMPLETED
17/03/2021
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
17/03/2021
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
11/03/2021
RFNT
REFUSAL PROCESSED BY IB
13/12/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/11/2020
RFRR
REFUSAL PROCESSED BY MPU
23/11/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/11/2020
CNRT
NON-FINAL ACTION WRITTEN
04/11/2020
DOCK
ASSIGNED TO EXAMINER
03/11/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LAMPLEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.